Ancestral-derived effects on the mutational landscape of laryngeal cancer by Ramakodi M. et al.
Ancestral-derived effects on themutational landscape of laryngeal cancer
Meganathan P. Ramakodi a,b,c,d, Rob J. Kulathinal b,c,d, Yujin Chung b,d, Ilya Serebriiskii e,f,
Jeffrey C. Liu a,g, Camille C. Ragin a,c,g,h,⁎
a Cancer Prevention and Control Program, Fox Chase Cancer Center-Temple Health, Philadelphia, PA 19111, USA
b Department of Biology, Temple University, Philadelphia, PA 19122, USA
c African-Caribbean Cancer Consortium
d Center for Computational Genetics and Genomics, Temple University, Philadelphia, PA 19122, USA
e Developmental Therapeutics, Fox Chase Cancer Center- Temple Health, Philadelphia, PA 19111, USA
f Kazan Federal University, Kazan, Russia
g Department of Otolaryngology - Head and Neck Surgery, Temple University School of Medicine, Philadelphia, PA 19140, USA
h College of Public Health, Temple University, Philadelphia, PA 19122, USA
a b s t r a c ta r t i c l e i n f o
Article history:
Received 17 August 2015
Received in revised form 26 November 2015
Accepted 21 December 2015
Available online 22 December 2015
Laryngeal cancer disproportionately affectsmoreAfrican-Americans than European-Americans.Here,we analyze
the genome-wide somatic point mutations from the tumors of 13 African-Americans and 57 European-
Americans from TCGA to differentiate between environmental and ancestrally-inherited factors. The mean
number of mutations was different between African-Americans (151.31) and European-Americans (277.63).
Other differences in the overall mutational landscape between African-American and European-American
were also found. The frequency of C N A, and C N G were signiﬁcantly different between the two populations
(p-value b 0.05). Context nucleotide signatures for some mutation types signiﬁcantly differ between these two
populations. Thus, the context nucleotide signatures along with other factors could be related to the observed
mutational landscape differences between two races. Finally, we show that mutated genes associated with
these mutational differences differ between the two populations. Thus, at the molecular level, race appears to
be a factor in the progression of laryngeal cancer with ancestral genomic signatures best explaining these
differences.









Laryngeal cancer afﬂicts approximately 12,000 new individuals in
the United States each year [1,2] with different incidence and survival
rates across ethnic groups [1]. This particular cancer type affects more
African-American (Afr-Amr) individuals than European-Americans
(Eur-Amr) [1] and the ﬁve year survival rate for Afr-Amr with laryngeal
cancer is consistently lower than that for Eur-Amr [1]. While socio-
economic factors and life styles are associatedwith the higher incidence
and lower survival rates among Afr-Amr [3], we have shown that the
contribution of an individual's genetics cannot be ignored [4].
The major risk factors for laryngeal cancer are tobacco smoke and
alcohol consumption [5,6]. Pro-carcinogens found in tobacco smoke
are absorbed by cells, metabolized to form active carcinogens, and
subsequently excreted from the body following detoxiﬁcation [7]. If
the active carcinogens are not excreted from the cell, the carcinogenic
compounds may bind to and ultimately damage DNA [7]. The effect
of alcohol with tobacco is synergistic; it is hypothesized that alcohol
accelerates the absorption and action of tobacco-based carcinogens
[8]. Defects in the enzyme activity or metabolic pathway of tobacco
metabolism may lead to the accumulation of tobacco carcinogens in
the body and increase the risk of tumor progression. Higher levels
of nicotine and cotinine (the major nicotine-based metabolite that
contributes to cancer development) have been reported in Afr-Amr
compared to individuals of European descent, irrespective of smoking
levels [9–12]. In addition, reduced metabolic clearance of nicotine to
cotinine and decreased excretions of nicotine and cotinine have been
observed in Afr-Amr, relative to Caucasians, for similar cigarette
consumption [11,12]. Genetic studies have identiﬁed gene variants
associated with reduced rates of nicotine metabolism in populations
with signiﬁcant African descent [13–15]. African-ancestry related
genetic variants associated with susceptibility to cancer chemothera-
peutic agents have also been demonstrated [16]. In addition, genetic
variants associated with increased risk for head and neck cancers in
patients of African descent have also been revealed by meta-analysis
[17]. These evidences suggest the possible role of genetic ancestry,
together with other non-genetic factors, in increased laryngeal cancer
risk and poor survival rate among Afr-Amr. Nevertheless, genome-
wide analysis to address the disparity issues in laryngeal cancer has
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